Business
Exscientia Wins Emerging Biotech Company Award
Exscientia Wins Emerging Biotech Company Award.
About this update from Frontier Ip Group Plc
[{"type":"text","content":"\n \nRNS Number : 9929S Frontier IP Group plc 09 October 2017 \n\n \nRNS REACH\nAIM: FIPP\n9th October 2017\n \nFrontier IP Group Plc\n(\"Frontier IP\" or the \"Group\")\n \nPortfolio News\nExscientia Wins Best Emerging Biotech Company Award\n \nFrontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that its portfolio company Exscientia Limited (\"Exscientia\") was the winner of the Best Emerging Biotech Company Award at the OBN Annual Awards ceremony, celebrating outstanding achievement in the UK life sciences sector, held 5th October in Oxford, UK. The full text of this announcement is set out below.\n \nExscientia Wins Best Emerging Biotech Company Award at OBN Annual Awards 2017\n \nExscientia, the leading Artificial Intelligence (AI)-driven drug discovery company, is pleased to announce that it was the winner of the Best Emerging Biotech Company Award at the OBN Annual Awards ceremony, celebrating outstanding achievement in the UK life sciences sector, held 5th October in Oxford, UK.\n \nThe award was presented to Andrew Hopkins, CEO of Exscientia, in recognition of the company's outstanding success in applying AI and big data processing to accelerate drug discovery and development. This success is highlighted by the company's collaborations with GSK, Sanofi and Evotec, representing a strong endorsement of Exscientia and validation of its approach. Through these collaborations, the company is developing single-target small molecules as well as compounds with more challenging target product profiles, through a novel bispecific small molecule strategy (compounds with dual pharmacology in an integrated pharmacophore) and phenotypic-driven drug design.\n \nThis award was judged by a panel of leading figures from the UK life sciences industry.\n \nOBN is the membership organisation supporting and bringing together the UK's emerging life sciences companies, corporate partners and investors. www.obn.org.uk \n \nAbout the OBN Annual Awards - www.obn-awards.com\nThe OBN Awards 2017, now in their 9th year, celebrate innovation and outstanding achievement across the UK Life Sciences industry. Categories are broad ranging and include Biotech, Medtech, Synthetic Biology, Digital Healthcare and Investment. This year they a...